Pneumocystis jirovecipneumonia in patients with rheumatoid arthritis treated with infliximab: A retrospective review and case-control study of 21 patients-Reference-Cited by-同舟云学术

Pneumocystis jirovecipneumonia in patients with rheumatoid arthritis treated with infliximab: A retrospective review and case-control study of 21 patients

Published:2009-03-15 Issue:3 Volume:61 Page:305-312
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Komano Yukiko,Harigai Masayoshi,Koike Ryuji,Sugiyama Haruhito,Ogawa Jun,Saito Kazuyoshi,Sekiguchi Naoya,Inoo Masayuki,Onishi Ikuko,Ohashi Hiroyuki,Amamoto Fujio,Miyata Masayuki,Ohtsubo Hideo,Hiramatsu Kazuko,Iwamoto Masahiro,Minota Seiji,Matsuoka Naoki,Kageyama Goichi,Imaizumi Kazuyoshi,Tokuda Hitoshi,Okochi Yasumi,Kudo Koichiro,Tanaka Yoshiya,Takeuchi Tsutomu,Miyasaka Nobuyuki

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.24283/fullpdf

Reference44 articles.

1. Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial;Maini;Lancet,1999

2. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial;Goekoop-Ruiterman;Arthritis Rheum,2005

3. Safety of tumour necrosis factor-α antagonists;Khanna;Drug Saf,2004

4. Benefit-risk assessment of infliximab in the treatment of rheumatoid arthritis;Mikuls;Drug Saf,2003

5. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials;Bongartz;JAMA,2006

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the outcomes of Pneumocystis jirovecii pneumonia in rheumatoid arthritis patients treated with and without biologics;Respiratory Investigation;2024-05

2. Response to “Do not ignore another risk factor of invasive fungal infections in patients with connective tissue disease”;Seminars in Arthritis and Rheumatism;2024-04

3. Risk factors for invasive fungal infections in patients with connective tissue disease: Systematic review and meta-analysis;Seminars in Arthritis and Rheumatism;2023-12

4. Risk Factors of Pneumocystis jirovecii Pneumonia in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study;Gut and Liver;2023-10-23

5. Position statement on infection screening, prophylaxis, and vaccination in pediatric patients with rheumatic diseases and immunosuppressive therapies, part 2: infection prophylaxis;European Journal of Pediatrics;2023-07-13